Showing results (291-300 of 416) with videos related to
Sort By:
Pageof 42
Journal of Translational Medicine|August 26, 2023
Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenograftsLydia Koi, Verena Bitto, Corina Weise, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 23, 2015
Residual γH2AX foci after ex vivo irradiation of patient samples with known tumour-type specific differences in radio-responsivenessApostolos Menegakis, Chiara De Colle, Ala Yaromina, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 9, 2018
FMISO-PET-based lymph node hypoxia adds to the prognostic value of tumor only hypoxia in HNSCC patientsAnna Bandurska-Luque, Steffen Löck, Robert Haase, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 4, 2018
Retrospective evaluation of decision-making for pancreatic stereotactic MR-guided adaptive radiotherapyMarguerite Tyran, Naomi Jiang, Minsong Cao, et al.Plos One|July 9, 2014
Using health surveillance systems data to assess the impact of AIDS and antiretroviral treatment on adult morbidity and mortality in BotswanaRand Stoneburner, Eline Korenromp, Mark Lazenby, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 25, 2022
Surveillance and epidemiology of syphilis, gonorrhoea and chlamydia in the non-European Union countries of the World Health Organization European Region, 2015 to 2020Jelena Barbaric, Giorgi Kuchukhidze, Nicole Seguy, et al.IEEE Open Journal of Engineering in Medicine and Biology|February 23, 2023
Artificial Intelligence for Detecting COVID-19 With the Aid of Human Cough, Breathing and Speech Signals: Scoping ReviewMouzzam Husain, Andrew Simpkin, Claire Gibbons, et al.International Journal of Radiation Oncology, Biology, Physics|July 22, 2015
Identification of Patient Benefit From Proton Therapy for Advanced Head and Neck Cancer Patients Based on Individual and Subgroup Normal Tissue Complication Probability AnalysisAnnika Jakobi, Anna Bandurska-Luque, Kristin Stützer, et al.Acta Oncologica (Stockholm, Sweden)|September 5, 2015
NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapyAnnika Jakobi, Kristin Stützer, Anna Bandurska-Luque, et al.Cancers|April 3, 2021
Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal CancerOliver J Ott, Cihan Gani, Lars H Lindner, et al.Pageof 42